Indications and uses
Helps prevent sunburn.
Illuminating Mineral Beauty Balm with SPF 9
- Manufacturer
- Mineral Fusion Natural Brands LLC | Columbia Cosmetics
- Effective date
- 2019-09-17
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 6
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 21:37:22
Label at a glance#
ProductIlluminating Mineral Beauty Balm with SPF 9
Active ingredientTITANIUM DIOXIDE
Label structure10 sections
Dosage and administration
Apply liberally 15 minutes before sun exposure. Use a water resistant sunscreen if swimming or sweating. Reapply at least every 2 hours. Children under 6 months: Ask a doctor.
Storage and handling
Protect this product from excessive heat and direct sun.
Contacts and useful links#
Label contents#
Full prescribing information#
SPL UNCLASSIFIED SECTION
Drug Facts
Active Ingredient
Titanium Dioxide 7.4%
Purpose
Sunscreen
Uses
- Helps prevent sunburn.
Warnings
Skin Cancer/Skin Aging Alert
Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to help prevent sunburn, not skin cancer or early aging.
- For external use only.
OTC - DO NOT USE SECTION
- Do not use on damaged or broken skin.
OTC - WHEN USING SECTION
- When using this product keep out of eyes. Rinse with water to remove.
OTC - STOP USE SECTION
- Stop use and ask a doctor if rash occurs.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
- Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.
Directions
Apply liberally 15 minutes before sun exposure.
- Use a water resistant sunscreen if swimming or sweating.
- Reapply at least every 2 hours.
- Children under 6 months: Ask a doctor.
Inactive Ingredients
Water (Aqua), Caprylic/Capric Triglyceride, Jojoba Esters, Mica, Vegetable Glycerin, Sorbitan Sesquioleate, Cetearyl Olivate, Sorbitan Olivate, Potassium Cetyl Phosphate, Dimethicone, Hydroxyethylcellulose, Citric Acid, Punica Granatum (Pomegranate) Extract, Tetrahexyldecyl Ascorbate (Vitamin C), Mineral-Peptide Blend (Magnesium Asparate, Zinc Gluconate, Copper Gluconate, and Palmitoyl Tripeptide-5), Camellia Sinensis (White Tea) Leaf Extract, Aloe Barbadensis Leaf Juice, Glycyrrhiza Glabra (Licorice) Extract, Lavandula Angustifolia (Lavender) Extract, Rosa Canina (Rose) Flower Extract, Olea Europaea (Olive) Leaf Extract, Potassium Sorbate, Sodium Dehydroacetate, Sodium Benzoate, Iron Oxides (CI 77491, CI 77492, CI 77499).
Other Information
Protect this product from excessive heat and direct sun.
Questions or Comments?
Call toll free 1-800-428-1668 Mon-Fri 8 AM-5 PM MST
PRINCIPAL DISPLAY PANEL - 60 ml Tube Label
MINERAL FUSION®
minerals on a mission®
illuminating
mineral beauty balm
broad spectrum SPF 9
LUMINOUS FINISH
Ultra-sheer for all skin tones
ALL-IN-ONE
BB
Makeup + moisturizer
+ age-defying treatment
Hypo-allergenic, Fragrance free
2.0 fl oz / 60 mL e
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 55789-2401-1 | 2025-01-30 | C162847 | 48780-1 | f386c649-d1c0-0266-e053-dadaa90a7c1a | Illuminating Mineral Beauty Balm with SPF 9 |
| 55789-2401-1 | 2023-02-06 | C162847 | 48780-1 | f386c649-d1c0-0266-e053-dadaa90a7c1a | Illuminating Mineral Beauty Balm with SPF 9 |
| 55789-2401-1 | 2023-01-30 | C162847 | 48780-1 | f386c649-d1c0-0266-e053-dadaa90a7c1a | Illuminating Mineral Beauty Balm with SPF 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 55789-2401 | ILLUMINATING MINERAL BEAUTY BALM WITH SPF 9 (TITANIUM DIOXIDE) CREAM [MINERAL FUSION NATURAL BRANDS LLC] | 6 | Legacy NDC | 20230208_3e6e97f8-1179-4ea4-a266-946f0ab7f480.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| Titanium Dioxide | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| Aloe Vera Leaf | INACTIVE INGREDIENT | ZY81Z83H0X | 1 | |
| Camellia Sinensis Flower | INACTIVE INGREDIENT | 9I2BJY2J17 | 1 | |
| Cetearyl Olivate | INACTIVE INGREDIENT | 58B69Q84JO | 1 | |
| Citric Acid Monohydrate | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| Copper Gluconate | INACTIVE INGREDIENT | RV823G6G67 | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| Ferric Oxide Red | INACTIVE INGREDIENT | 1K09F3G675 | 1 | |
| Glycerin | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| Glycyrrhiza Glabra | INACTIVE INGREDIENT | 2788Z9758H | 1 | |
| Hydroxyethyl cellulose (100 MPA.S at 2%) | INACTIVE INGREDIENT | R33S7TK2EP | 1 | |
| Jojoba Oil | INACTIVE INGREDIENT | 724GKU717M | 1 | |
| Lavandula Angustifolia Flowering Top | INACTIVE INGREDIENT | 9YT4B71U8P | 1 | |
| Magnesium Aspartate | INACTIVE INGREDIENT | R17X820ROL | 1 | |
| Medium-Chain Triglycerides | INACTIVE INGREDIENT | C9H2L21V7U | 1 | |
| Mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| Olea Europaea Leaf | INACTIVE INGREDIENT | MJ95C3OH47 | 1 | |
| Palmitoyl Tripeptide-5 | INACTIVE INGREDIENT | 2A3916MQHO | 1 | |
| Potassium Cetyl Phosphate | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| Potassium Sorbate | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| Punica Granatum Root Bark | INACTIVE INGREDIENT | CLV24I3T1D | 1 | |
| Rosa Canina Fruit | INACTIVE INGREDIENT | 3TNW8D08V3 | 1 | |
| Sodium Benzoate | INACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| Sodium Dehydroacetate | INACTIVE INGREDIENT | 8W46YN971G | 1 | |
| Sorbitan Olivate | INACTIVE INGREDIENT | MDL271E3GR | 1 | |
| Sorbitan Sesquioleate | INACTIVE INGREDIENT | 0W8RRI5W5A | 1 | |
| Tetrahexyldecyl Ascorbate | INACTIVE INGREDIENT | 9LBV3F07AZ | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| Zinc Gluconate | INACTIVE INGREDIENT | U6WSN5SQ1Z | 1 |
Products#
Every source-derived product name is available through these pages.
- Illuminating Mineral Beauty Balm with SPF 9
- Titanium Dioxide
- WATER
- MEDIUM-CHAIN TRIGLYCERIDES
- JOJOBA OIL
- MICA
- GLYCERIN
- SORBITAN SESQUIOLEATE
- CETEARYL OLIVATE
- SORBITAN OLIVATE
- POTASSIUM CETYL PHOSPHATE
- DIMETHICONE
- HYDROXYETHYL CELLULOSE (100 MPA.S AT 2%)
- CITRIC ACID MONOHYDRATE
- PUNICA GRANATUM ROOT BARK
- TETRAHEXYLDECYL ASCORBATE
- MAGNESIUM ASPARTATE
- COPPER GLUCONATE
- PALMITOYL TRIPEPTIDE-5
- CAMELLIA SINENSIS FLOWER
- ALOE VERA LEAF
- GLYCYRRHIZA GLABRA
- LAVANDULA ANGUSTIFOLIA SUBSP. ANGUSTIFOLIA FLOWERING TOP
- ROSA CANINA FRUIT
- OLEA EUROPAEA LEAF
- POTASSIUM SORBATE
- SODIUM DEHYDROACETATE
- SODIUM BENZOATE
- FERRIC OXIDE RED
- ZINC GLUCONATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 55789-2401 | 55789-2401-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, DELAYED RELEASE / ORAL | 37 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| Potassium Sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | TABLET / ORAL | 6 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CREAM / VAGINAL | 0.49 %w/w | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, CHEWABLE / ORAL | 2 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | 864 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAMUSCULAR | 450 mg | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET / ORAL | 8 mg | ||
| Sorbitan Sesquioleate | SORBITAN SESQUIOLEATE | 0W8RRI5W5A | OINTMENT / RECTAL | 15 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET / ORAL | 914 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | CREAM / TOPICAL | 0.2 %w/w | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | POWDER / SUBLINGUAL | 2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER / ORAL | 840 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | INJECTION, SOLUTION / INTRAMUSCULAR | 4.8 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION/ DROPS / AURICULAR (OTIC) | 25 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / AURICULAR (OTIC) | 0.2 %w/v | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | EMULSION / OPHTHALMIC | 3 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET, CHEWABLE / ORAL | 12 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | SOLUTION / ORAL | 5566 mg | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | FILM, EXTENDED RELEASE / TRANSDERMAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION, CONCENTRATE / INTRAVENOUS | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / NASAL | 2.8 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| Medium-Chain Triglycerides | MEDIUM-CHAIN TRIGLYCERIDES | C9H2L21V7U | TABLET, EXTENDED RELEASE / ORAL | 0.37 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | JELLY / VAGINAL | NA | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| Potassium Sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SHAMPOO, SUSPENSION / TOPICAL | 0.25 %w/v | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / RESPIRATORY (INHALATION) | 0.13 %w/w | ||
| Ferric Oxide Red | FERRIC OXIDE RED | 1K09F3G675 | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 3.6 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SOFT TISSUE | ADJ PH | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / PERIODONTAL | 0.53 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | INJECTION / INTRAVENOUS | 33750 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DROPS / NASAL | 10 mg/1ml | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SOLUTION / DENTAL | 15 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | TABLET / ORAL | 42 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 1 mg | ||
| Sodium Benzoate | SODIUM BENZOATE | OJ245FE5EU | ENEMA / RECTAL | 60 mg | ||
| Potassium Sorbate | POTASSIUM SORBATE | 1VPU26JZZ4 | CAPSULE / ORAL | NA | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE, EXTENDED RELEASE / ORAL | 101 mg | ||
| Citric Acid Monohydrate | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION/ DROPS / TOPICAL | 0.01 %w/v | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| Glycerin | GLYCERIN | PDC6A3C0OX | DOUCHE / VAGINAL | 1 %w/w | ||
| Sorbitan Sesquioleate | SORBITAN SESQUIOLEATE | 0W8RRI5W5A | OINTMENT / TOPICAL | 75 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 42a32a3f-6c89-4ced-8463-f780d73ae8cb | 3e6e97f8-1179-4ea4-a266-946f0ab7f480 | 2026-03-12 | Warnings | 3e6e97f8-1179-4ea4-a266-946f0ab7f480 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.